KRAS and cancer: After induction of Cre recombinase- which renders these cells “Rasless” [21]- cells were reconstituted with comparable expression levels of either wild type KRAS 4B or commonly mutated forms of KRAS 4B (hereafter referred to as KRAS; cell line panel available from the Ras initiative at the NIH national cancer institute, US).